Abstract | BACKGROUND: New dietary strategies to reduce cardiovascular disease (CVD) risk include the addition of fiber to the diet. The effect of soluble-fiber consumption derived from Plantago ovata husk on lipid risk factors in patients with CVD is unknown. OBJECTIVE: DESIGN: In a randomized, crossover, controlled, single-blind design, 28 men with CVD ( myocardial infarction or stable angina) and an LDL-cholesterol concentration </=3.35 mmol/L consumed for 8 wk, under controlled conditions, a low-saturated-fat diet supplemented with 10.5 g P. ovata husk/d or 10.5 g P. ovata seeds/d. Fasting plasma lipid concentrations and polymorphisms of genes involved in lipid metabolism, such as apo A-IV, apo E, and fatty acid-binding protein, were measured. RESULTS: Plasma triacylglycerol decreased (6.7%; P < 0.02), the ratio of apo B 100 to apo A-I decreased (4.7%; P < 0.02), and apo A-I increased (4.3%; P < 0.01) in the P. ovata husk consumers. Compared with the intake of insoluble fiber, the intake of P. ovata husk increased HDL-cholesterol concentrations by 6.7% (P = 0.006) and decreased the ratio of total to HDL cholesterol and of LDL to HDL cholesterol by 10.6% (P = 0.002) and 14.2% (P = 0.003), respectively. CONCLUSION: In the secondary prevention of CVD, P. ovata husk intake induces a more beneficial effect on the cardiovascular lipid risk-factor profile than does an equivalent intake of insoluble fiber.
|
Authors | Rosa Solà, Gemma Godàs, Josep Ribalta, Joan-Carles Vallvé, Josefa Girona, Anna Anguera, Maadoracion Ostos, Delia Recalde, Juliana Salazar, Muriel Caslake, Francisco Martín-Luján, Jordi Salas-Salvadó, Lluís Masana |
Journal | The American journal of clinical nutrition
(Am J Clin Nutr)
Vol. 85
Issue 4
Pg. 1157-63
(Apr 2007)
ISSN: 0002-9165 [Print] United States |
PMID | 17413119
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins
- Dietary Fiber
- Lipids
- Lipoproteins
|
Topics |
- Angina Pectoris
(blood, diet therapy, genetics)
- Apolipoproteins
(blood)
- Cross-Over Studies
- Dietary Fiber
(administration & dosage, pharmacology)
- Genotype
- Humans
- Lipids
(blood)
- Lipoproteins
(blood)
- Male
- Middle Aged
- Myocardial Infarction
(blood, diet therapy, genetics)
- Myocardial Ischemia
(blood, diet therapy, genetics)
- Patient Compliance
- Plantago
- Single-Blind Method
- Solubility
|